Voloridge Investment Management
RXST icon

Voloridge Investment Management’s RxSight RXST Stock Holding History

Voloridge Investment Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-180,776
Closed -$1.63M – 1330
2025
Q3 		$1.63M Sell
180,776
-220,859
-55% -$1.94M 0.01% 964
2025
Q2 		$5.22M Sell
401,635
-124,247
-24% -$1.87M 0.02% 741
2025
Q1 		$13.3M Buy
525,882
+160,265
+44% +$4.76M 0.05% 477
2024
Q4 		$12.6M Buy
365,617
+212,599
+139% +$9.59M 0.04% 509
2024
Q3 		$7.56M Sell
153,018
-195,011
-56% -$9.99M 0.03% 668
2024
Q2 		$20.9M Sell
348,029
-28,245
-8% -$1.61M 0.08% 349
2024
Q1 		$19.4M Buy
376,274
+78,380
+26% +$3.85M 0.07% 336
2023
Q4 		$12M Sell
297,894
-58,749
-16% -$1.72M 0.05% 433
2023
Q3 		$9.95M Buy
356,643
+174,488
+96% +$5.2M 0.05% 463
2023
Q2 		$5.25M Buy
+182,155
New +$4.05M 0.02% 656

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Voloridge Investment Management's RXST Position: Q4 2025 in Review

Voloridge Investment Management sold out of RxSight (RXST) in Q4 2025, closing a stake of 180,776 shares — an estimated $1.63M sold.

Voloridge Investment Management first reported a position in RXST in Q2 2023 and held it in 10 quarters. The position peaked at $20.9M in Q2 2024. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

  • Voloridge Investment Management reported no remaining RxSight position as of Q4 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 180,776 RxSight shares in Q4 2025, an estimated $1.63M.
  • Voloridge Investment Management first reported a position in RxSight in Q2 2023 and held it in 10 quarters.
  • Voloridge Investment Management's RxSight position peaked at $20.9M in Q2 2024.
  • 163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.